Kawasan Industri Jababeka Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Kawasan Industri Jababeka Tbk. trades at Rp140 (market cap 2.73T, 320.66M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Kawasan Industri Jababeka Tbk. is far larger — about 4.7× UBC Medical Indonesia Tbk.'s market cap, and Kawasan Industri Jababeka Tbk. is more actively traded (320.66M versus 3.48M). Which is the better fit depends on your goals.
| KIJA | LABS | |
|---|---|---|
Market Cap | 2.73T | 576.7B |
Volume | 320.66M | 3.48M |
Lot | 3.21M | 34.82K |
Turnover | 44.45B | 522.79M |
Average Price | 138.62 | 150.13 |
Value | 44.45B | 522.79M |
Indicative Equilibrium Price | 140 | 148 |
Indicative Equilibrium Volume | 64.18K | 350 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kawasan Industri Jababeka Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No.6 year 1968 which was amended by Law No.12 year 1970, based on notarial deed No.18 of Maria Kristiana Soeharyo, S.H., dated January 12, 1989. The Company started its commercial operations in 1990. The Companys shares are listed on JSX and SSX.
Read more on KIJA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →